Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
SOSV
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Asgard TherapeuticsSeries A $32.4M · 2 yr ago • 51-200 employees
Reprogramming is the next leap forward in cancer immunotherapy. Asgard Therapeutics is a Swedish private biotech company exploring direct…
AvenCellSeries B $112M · 23 mo ago
Next generation immunotherapies for hard-to-treat cancers that are allogeneic and switchable.
Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Pixelgen TechnologiesSeries B $15.5M · 2 mo ago • Founded 2020 • 51-200 employees
Molecular Cell Architecture - Life at the highest resolution. Pixelgen Technologies' mission is to provide insights into biology at the…
Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune…
Laguna is a biotechnology company developing next-generation attenuated microbial platforms that have the predictable PK/PD of small…

Overview

Rybodyn unlocks the dark proteome to develop first-in-class immunotherapies with AI and high-resolution RNA sequencing via its RyboCypher™ platform.